ArticleInternational journal of biological sciences2024

Dual-Multivalent Aptamer-Based Drug Delivery Platform for Targeted SRC Silencing to Enhance Doxorubicin Sensitivity in Endometrial Cancer.

Haojia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.